Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Pain and Headache Reports
Erschienen in: Current Pain and Headache Reports 2/2014

01.02.2014 | CHRONIC DAILY HEADACHE (S J WANG, SECTION EDITOR)

Occipital Nerve Stimulation for Chronic Migraine

verfasst von: William B. Young

Erschienen in: Current Pain and Headache Reports | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Occipital nerve stimulation may be effective in treating chronic migraine. Six studies, including three double-blind studies, were performed, with five showing evidence of benefit. However, of the three randomized, controlled trials, none has met a primary endpoint successfully. A separate study suggested a benefit for combined supraorbital and greater occipital nerve stimulation.
Literatur
1.
Bigal ME, Serrano D, Reed M, et al. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71:559–66.PubMedCrossRef
2.
Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30:599–609.PubMed
3.
Headache Classification Committee. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia. 2004;24:1–160.
4.
Bigal ME, Rapoport AM, Lipton RB, et al. Assessment of migraine disability using the Migraine Disabiilty Assessment (MIDAS) Questionnaire: a comparison of chronic migraine with episodic migraine. Headache. 2003;43:336–42.PubMedCrossRef
5.
Munakata J, Hazard E, Serrano D, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache. 2009;49:498–508.PubMedCrossRef
6.
Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31:301–15.PubMedCrossRef
7.
Meletiche DM, Lofland JH, Young WB. Quality of life differences between patients with episodic and transformed migraine. Headache. 2001;41:573–8.PubMedCrossRef
8.
Popeney CA, Alo KM. Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache. 2003;43:369–75.PubMedCrossRef
9.
Oh MY, Ortega J, Bellotte JB, et al. Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a c1-2-3 subcutaneous paddle style electrode: a technical report. Neuromodulation. 2004;7:103–12.PubMedCrossRef
10.
Schwedt TJ, Dodick DW, Hentz J, et al. Occipital nerve stimulation for chronic headache–long-term safety and efficacy. Cephalalgia. 2007;27:153–7.PubMedCrossRef
11.••
Reed KL, Black SB, Banta CJ, et al. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia. 2010;30:260–71. Study examines combined occipital and supraorbital nerve stimulation. Combined stimulation was substantially more effective than previous reports for ONS alone.PubMed
12.•
Lipton RB, Goadsby PJ, Cady RK, et al. PRISM study: occipital nerve stimulation for treatment-refractory migraine. Cephalalgia. 2009;29:30-Abstract PO47. The third sham-controlled trial. Results were negative and only the abstract was reported
13.••
Saper JR, Dodick DW, Silberstein SD, et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31:271–85. Double-blind, sham-controlled trial to explore various endpoints. Occipital nerve block responders were excluded, but implanted.PubMedCentralPubMedCrossRef
14.••
Silberstein SD, Dodick D, Saper J, et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blind, controlled study. Cephalalgia. 2012;32:1165–79. Large, double-blind, controlled study. The primary endpoint of 50 % improvement in average VAS score proved negative. A 30 % improvement would have proved positive.PubMedCrossRef
15.
Diener HC, Schorn CF, Bingel U, et al. The importance of placebo in headache research. Cephalalgia. 2008;28:1003–11.PubMedCrossRef
16.
Serra G, Marchioretto F. Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician. 2012;15:245–53.PubMed
17.
Anthony M. Headache and the greater occipital nerve. Clin Neurol Neurosurg. 1992;94:297–301.PubMedCrossRef
18.
Austad EA. Can proximity of the occipital artery to the greater occipital nerve act as a cause of idiopathic greater occipital nerualgia? An anatomical and histological evaluation of the artery-nerve relationship. Plastic Reconstructive Surg. 2007;119:2035–6.CrossRef
19.
Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation. 1999;2:217–21.PubMedCrossRef
20.
Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004;127:220–30.PubMedCrossRef
21.
Vadivelu S, Bolognese P, Milhorat TH, et al. Occipital nerve stimulation for refractory headache in the Chiari malformation population. Neurosurgery. 2012;70:1430–6.PubMedCrossRef
22.
Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain. 2003;126:1801–13.PubMedCrossRef
23.
Wall PD. The gate control theory of pain mechanisms. A re-examination and re-statement. Brain. 1978;101:1–18.PubMedCrossRef
24.
Oshinsky ML, Hirata H, Poletto C, et al. Dural sensitization is suppressed by occipital nerve stimulation. 701.07/RR2. Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience; 2011.
25.
Stiller CO, Linderoth B, O'Connor WT, et al. Repeated spinal cord stimulation decreases the extracellular level of gamma-aminobutyric acid in the periaqueductal gray matter of freely moving rats. Brain Res. 1995;699:231–41.PubMedCrossRef
26.•
Lambru G, Matharu MS. Occipital nerve stimulation in primary headache syndromes. Ther Adv Neurol Disord. 2012;5:57–67. A well-written review of ONS in not just CM, but cluster headache, hemicrania continua, and Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) and Short-lasting Unilateral Neuralgiform headache Attacks with cranial autonomic features (SUNA).
Metadaten
Titel
Occipital Nerve Stimulation for Chronic Migraine
verfasst von
William B. Young
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports / Ausgabe 2/2014
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-013-0396-x

Weitere Artikel der Ausgabe 2/2014

Current Pain and Headache Reports 2/2014 Zur Ausgabe

Cancer Pain (D Marcus, Section Editor)

Managing Difficult Pain Conditions in the Cancer Patient

Cancer Pain (D Marcus, Section Editor)

Considerations for Evaluating the Use of Intrathecal Drug Delivery in the Oncologic Patient

Neuromodulation (M Gofeld, Section Editor)

Rehabilitation Perspectives of Neuromodulation

Anesthetic Techniques in Pain Management (D Wang, Section Editor)

Celiac Plexus Block in the Management of Chronic Abdominal Pain

Neuromodulation (M Gofeld, Section Editor)

Neuromodulation for Intractable Headaches

Neu im Fachgebiet AINS

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise